These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7294231)

  • 21. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma haloperidol levels and clinical response.
    Smith RC
    Arch Gen Psychiatry; 1987 Dec; 44(12):1110-2. PubMed ID: 3689100
    [No Abstract]   [Full Text] [Related]  

  • 23. Carbamazepine-induced reduction of blood levels of haloperidol in chronic schizophrenia.
    Kidron R; Averbuch I; Klein E; Belmaker RH
    Biol Psychiatry; 1985 Feb; 20(2):219-22. PubMed ID: 3971003
    [No Abstract]   [Full Text] [Related]  

  • 24. Haloperidol metabolism and antipsychotic effect in schizophrenia.
    Altamura AC; Mauri MC; Cavallaro R; Gorni A
    Lancet; 1987 Apr; 1(8536):814-5. PubMed ID: 2882227
    [No Abstract]   [Full Text] [Related]  

  • 25. Ketone reductase activity and reduced haloperidol/haloperidol ratios in haloperidol-treated schizophrenic patients.
    Huang HF; Jann MW; Tseng YT; Chung MC; Chien CP; Chang WH
    Psychiatry Res; 1995 Jul; 57(2):101-8. PubMed ID: 7480377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sexual disturbances during clozapine and haloperidol treatment for schizophrenia.
    Hummer M; Kemmler G; Kurz M; Kurzthaler I; Oberbauer H; Fleischhacker WW
    Am J Psychiatry; 1999 Apr; 156(4):631-3. PubMed ID: 10200746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of haloperidol in high doses in schizophrenia. Clinical, biochemical and pharmacokinetic study].
    Scatton B; Zarifian E; Bianchetti G; Cuche H; Loo H; Morselli PL
    Encephale; 1982; 8(1):1-8. PubMed ID: 7094868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays.
    Smith RC; Baumgartner R; Misra CH; Mauldin M; Shvartsburd A; Ho BT; DeJohn C
    Arch Gen Psychiatry; 1984 Nov; 41(11):1044-9. PubMed ID: 6497566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoxetine augmentation of haloperidol in chronic schizophrenia.
    Shim JC; Kelly DL; Kim YH; Yoon YR; Park JH; Shin JG; Conley RR
    J Clin Psychopharmacol; 2003 Oct; 23(5):520-2. PubMed ID: 14520132
    [No Abstract]   [Full Text] [Related]  

  • 30. Blood levels of haloperidol in schizophrenic patients.
    Shvartsburd A; Dekirmenjian H; Smith RC
    J Clin Psychopharmacol; 1983 Feb; 3(1):7-12. PubMed ID: 6833528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haloperidol dose, plasma levels, and clinical response: a double-blind study [proceedings].
    Ericksen SE; Hurt SW; Chang S
    Psychopharmacol Bull; 1978 Apr; 14(2):15-6. PubMed ID: 349597
    [No Abstract]   [Full Text] [Related]  

  • 32. Haloperidol plasma levels and dose optimization.
    Coryell W; Miller DD; Perry PJ
    Am J Psychiatry; 1998 Jan; 155(1):48-53. PubMed ID: 9433338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lithium and haloperidol.
    Nemes ZC; Volavka J; Cooper TB; O'Donnell J; Jaeger J
    Biol Psychiatry; 1986 May; 21(5-6):568-9. PubMed ID: 3697447
    [No Abstract]   [Full Text] [Related]  

  • 34. Haloperidol blood levels and effects in schizophrenia and schizoaffective disorder: a progress report.
    Volavka J; Cooper TB; Meisner M; Bitter I; Czobor P; Jaeger J
    Psychopharmacol Bull; 1990; 26(1):13-7. PubMed ID: 2371368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between serum concentration and therapeutic effect of haloperidol in patients with acute schizophrenia.
    Ulrich S; Wurthmann C; Brosz M; Meyer FP
    Clin Pharmacokinet; 1998 Mar; 34(3):227-63. PubMed ID: 9533984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical state, plasma levels of haloperidol and prolactin: a correlation study in chronic schizophrenia.
    Rao VA; Bishop M; Coppen A
    Br J Psychiatry; 1980 Dec; 137():518-21. PubMed ID: 7214106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pimozide versus Haloperidol in acute schizophrenia. A double blind controlled study.
    Haas S; Beckmann H
    Pharmacopsychiatria; 1982 Mar; 15(2):70-4. PubMed ID: 7043498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haloperidol plasma levels and clinical response: a therapeutic window relationship.
    Van Putten T; Marder SR; Mintz J; Poland RE
    Am J Psychiatry; 1992 Apr; 149(4):500-5. PubMed ID: 1554036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical response and serum neuroleptic levels in childhood schizophrenia.
    Meyers B; Tune LE; Coyle JT
    Am J Psychiatry; 1980 Apr; 137(4):483-4. PubMed ID: 7361939
    [No Abstract]   [Full Text] [Related]  

  • 40. Haloperidol pharmacokinetics following gastric bypass surgery.
    Fuller AK; Tingle D; DeVane CL; Scott JA; Stewart RB
    J Clin Psychopharmacol; 1986 Dec; 6(6):376-8. PubMed ID: 3805335
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.